BBNX — Beta Bionics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1674632 ·
Last close
$13.19
Market Cap
$587.77M
52W High
$15.00
52W Low
$8.80
ADV30
875,580
Next earnings
2026-07-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 27,626,000 | 16,437,000 | -24,271,000 | -21,895,000 | 304,417,000 | 30,206,000 | 33,172,000 |
| Dec 2025 | 32,121,000 | 18,944,000 | -16,124,000 | -13,466,000 | 328,743,000 | 31,576,000 | 41,133,000 |
| Sep 2025 | 27,253,000 | 15,119,000 | -17,043,000 | -14,209,000 | 330,046,000 | 38,485,000 | 35,286,000 |
| Jun 2025 | 23,238,000 | 12,503,000 | -19,872,000 | -16,869,000 | 329,971,000 | 35,075,000 | 28,338,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-54,782,000
Investing CF
$38,156,000
Financing CF
$4,378,000
CapEx
$-6,341,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.51
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-391,832,000
Inventory
$23,727,000
Receivables
$18,138,000
ST Investments
$169,314,000
EBIT TTM
$-73,134,000
Pretax Income TTM
$-66,439,000
Interest Exp TTM
—
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$110,238,000
EBITDA
$-75,455,000
Free Cash Flow
$-44,055,752
Enterprise Value
$429,027,648
Total Cash
$199,520,000
Total Debt
$6,912,000
Shares Out
44,561,695
Trailing EPS
$-1.37
Book Value
$6.09
ROE
-22.7%
ROA
-15.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 100,251,000 | -71,681,000 | -73,200,000 | 328,743,000 | 41,133,000 | — | -50,925,000 |
| Dec 2024 | 65,124,000 | -45,251,000 | -54,756,000 | 149,645,000 | 395,005,000 | — | -48,273,000 |
| Dec 2023 | 11,995,000 | -35,850,000 | -44,099,000 | 110,040,000 | 313,145,000 | — | -32,445,000 |
| Dec 2022 | 179,000 | -65,844,000 | -64,751,000 | 35,527,000 | 205,561,000 | — | -60,208,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.39
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $10.00 · spot: $13.19 · call volume: 200 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $582.63M | $25.83 | — |
| BVS | Bioventus Inc. | $578.57M | $8.54 | — |
| BWAY | Brainsway Ltd. | $578.18M | $14.41 | — |
| SGP | SpyGlass Pharma, Inc. | $608.49M | $18.20 | — |
| MDXG | MIMEDX GROUP, INC. | $537.69M | $3.61 | — |
News headlines (Yahoo Finance, 1h cache)
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
2026-06-02 13:00 · Yahoo
Beta Bionics to launch its first insulin patch pump to compete with Insulet
2026-05-26 10:15 · Yahoo
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
2026-05-21 20:04 · Yahoo
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
2026-05-15 22:50 · Yahoo
Robert Bruce's Strategic Moves: A Closer Look at Beta Bionics Inc's Impactful Addition
2026-05-14 21:05 · Yahoo
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
2026-05-13 06:05 · Yahoo
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation
2026-05-12 12:03 · Yahoo
Beta Bionics to Present at the Bank of America Securities Health Care Conference
2026-04-27 20:25 · Yahoo
Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Gr
2026-04-23 08:30 · Yahoo
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
2026-04-22 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.